Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study. [electronic resource]
Producer: 20010823Description: 597-602 p. digitalISSN:- 0735-7907
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Black People
- Carboplatin -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- Humans
- Middle Aged
- Midwestern United States
- Ovarian Neoplasms -- drug therapy
- Recombinant Proteins -- administration & dosage
- Survival Rate
- White People
- Black or African American
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.